{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:11:31Z","timestamp":1791727891932,"version":"4.3.4"},"reference-count":49,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antipsychotic medications are used in a wide range of mental health and neurodevelopmental conditions in children and adolescents. Their efficacy and tolerability with long-term use have not been clearly established. We aimed to conduct a systematic review and meta-analysis to evaluate the long-term use of antipsychotics in children and adolescents. All relevant double-blind randomized control trials (RCTs), on any antipsychotic used for 12 weeks or longer in any mental health\/neurodevelopmental condition in this age group, were included. We evaluated several efficacy and tolerability measures. Meta-analysis was performed for adverse events. Seven RCTs were identified (n = 939, age = 5-17 years), four on aripiprazole and three on risperidone. All studies reported symptomatic\/functional improvements or more time before discontinuation with antipsychotics compared to placebo. Weight gain was identified as a significant side effect with antipsychotics. Serum prolactin was reduced with aripiprazole and increased with risperidone, and abdominal pain\/discomfort, respiratory tract infections, were more common with Aripiprazole compared to placebo. Musculoskeletal pain may be more common with aripiprazole compared to placebo. Use of antipsychotics for 12 weeks or longer may be associated with symptomatic\/functional improvements, but may be associated with additional side effects compared to short-term treatment. Further research in this population is needed.<\/jats:p>","DOI":"10.1017\/s1092852921000523","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T10:17:22Z","timestamp":1621851442000},"page":"570-587","source":"Crossref","is-referenced-by-count":13,"title":["Antipsychotic long-term treatment in children and young people: a systematic review and meta-analysis of efficacy and tolerability across mental health and neurodevelopmental conditions"],"prefix":"10.1017","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-4516","authenticated-orcid":false,"given":"Pushpika","family":"Singappuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Sonuga-Barke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4594-2646","authenticated-orcid":false,"given":"Marinos","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"S1092852921000523_r27","doi-asserted-by":"publisher","DOI":"10.1089\/104454603321666216"},{"key":"S1092852921000523_r32","unstructured":"32. Higgins, JPT , Green, S . Chapter 9: summarizing study characteristics and preparing for synthesis. In: Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, Version 5.2.0; 2011:1\u201361."},{"key":"S1092852921000523_r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2017.06.013"},{"key":"S1092852921000523_r21","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-011-0678-1"},{"key":"S1092852921000523_r40","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.0159"},{"key":"S1092852921000523_r15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/cap.2017.0006","article-title":"Physical health outcomes in preschoolers with prior authorization for antipsychotics","volume":"27","author":"Wei","year":"2017","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"S1092852921000523_r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.08.009"},{"key":"S1092852921000523_r16","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2000.10.79"},{"key":"S1092852921000523_r48","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1337"},{"key":"S1092852921000523_r36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4088\/JCP.11m07104","article-title":"Double-blind randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder","volume":"73","author":"Findling","year":"2012","journal-title":"J Clin Psychiatry."},{"key":"S1092852921000523_r12","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12156"},{"key":"S1092852921000523_r23","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0656-6"},{"key":"S1092852921000523_r18","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182962480"},{"key":"S1092852921000523_r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2004.06.006"},{"key":"S1092852921000523_r25","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0027"},{"key":"S1092852921000523_r46","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00011"},{"key":"S1092852921000523_r2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","article-title":"A multi-national comparison of antipsychotic drug use in children and adolescents, 2005\u20132012","volume":"11","author":"Kalverdijk","year":"2017","journal-title":"Child Adolesc Psychiatry Ment Health."},{"key":"S1092852921000523_r47","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0307"},{"key":"S1092852921000523_r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.12.018"},{"key":"S1092852921000523_r14","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0688-2"},{"key":"S1092852921000523_r30","unstructured":"30. PROSPERO. International Prospective Register of Systematic Reviews. Centre for Reviews and Dissemination, University of York, United Kingdom. www.crd.york.ac.uk\/prospero."},{"key":"S1092852921000523_r34","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12042"},{"key":"S1092852921000523_r3","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414538675"},{"key":"S1092852921000523_r41","doi-asserted-by":"publisher","DOI":"10.1136\/adc.51.3.170"},{"key":"S1092852921000523_r35","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0081"},{"key":"S1092852921000523_r26","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000145805.24274.09"},{"key":"S1092852921000523_r37","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08500"},{"key":"S1092852921000523_r45","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.1088"},{"key":"S1092852921000523_r31","unstructured":"31. RevMan. The Cochrane Collaboration, Version 5.3; 2014."},{"key":"S1092852921000523_r1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.647"},{"key":"S1092852921000523_r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.04.018"},{"key":"S1092852921000523_r8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00750.x"},{"key":"S1092852921000523_r22","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0098"},{"key":"S1092852921000523_r39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.3.402"},{"key":"S1092852921000523_r33","unstructured":"33. Higgins, JPT , Green, S . Chapter 8: assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, Version 5.2.0; 2011:1\u201372."},{"key":"S1092852921000523_r5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"S1092852921000523_r4","first-page":"25","article-title":"Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012","volume":"111","author":"Bachmann","year":"2014","journal-title":"Dtsch Arztebl."},{"key":"S1092852921000523_r11","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31812eed10"},{"key":"S1092852921000523_r19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05933"},{"key":"S1092852921000523_r49","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76658"},{"key":"S1092852921000523_r9","first-page":"9","article-title":"Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents","volume":"69","author":"Findling","year":"2008","journal-title":"J Clin Psychiatry."},{"key":"S1092852921000523_r42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","journal-title":"Arch Dis Child."},{"key":"S1092852921000523_r6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.6.1142"},{"key":"S1092852921000523_r20","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200202000-00007"},{"key":"S1092852921000523_r10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/pcn.12681","article-title":"Safety and efficacy from a 6-week double-blind study and a 52-week open-label extension of aripiprazole in adolescents with schizophrenia in Japan","volume":"72","author":"Matsumoto","year":"2018","journal-title":"Psychiatry Clin Neurosci."},{"key":"S1092852921000523_r43","doi-asserted-by":"publisher","DOI":"10.1136\/adc.45.239.13"},{"key":"S1092852921000523_r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.02.032"},{"key":"S1092852921000523_r29","unstructured":"29. Higgins, JPT , Green, S . Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, Version 5.2.0; 2011."},{"key":"S1092852921000523_r17","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13081130"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852921000523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T10:26:52Z","timestamp":1666693612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852921000523\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1092852921000523"],"URL":"https:\/\/doi.org\/10.1017\/s1092852921000523","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}